Perspectives, Stories

Dear Doctor: Your patient is off his/her medication

Provider letters is associated with a big impact on medication adherence

May 21, 2016

Sending provider letters is associated with a significant impact on medication adherence

This study looked at members taking drugs in the three CMS Star rating categories: diabetes, high cholesterol and high blood pressure. When some of those members became non-adherent, their doctors were sent letters. A significant percentage of the members (up to 16%) whose doctors received letters became adherent again. This simple intervention provided an effective result.

Impact of provider mailings on medication adherence in Medicare Part D members (Spring 2014)

About Prime Therapeutics

Prime Therapeutics LLC (Prime) is a diversified pharmacy solutions organization serving health plans, employers and government programs. Prime is collectively owned by 19 Blue Cross and Blue Shield Plans, subsidiaries or affiliates of those plans. Magellan Rx Management, a Prime Therapeutics LLC Company, is a pioneer in specialty and medical drug management and a leader in serving public sector state government programs. Together Prime and Magellan Rx provide a wide range of clients with solutions that bridge the distance between medical and pharmacy management. For more information visit www.primetherapeutics.com and www.magellanrx.com, or follow us on Twitter at @Prime_PBM and @Magellan_Rx.

Related news

Perspectives

March 24, 2023

Look for Prime + Magellan Rx at AMCP 2023

Dr. Prerak Parikh (far left) and Dr. Sneha Sharma (far right) discuss trends…

Read More

Perspectives

March 23, 2023

Top female finance executive encourages DEI narrative

Over the past 30 years women’s careers in finance have seen significant progress,…

Read More

Perspectives

March 21, 2023

Top 10 acronyms in drug pipeline content, Part 2

News about biosimilars is everywhere. Sometimes you just need the basics. This four-part…

Read More
View all news